儿茶酚胺类药物在休克救治中的不良反应  

Adverse reactions of catecholamines in shock treatment

作　　者：曲东[1] 任晓旭[1] Qu Dong;Ren Xiaoxu(Children＇s Hospital Affiliated to the Capital Institute of Pediatrics ,Beijing 100020, China)

机构地区：[1]首都儿科研究所附属儿童医院,北京100020

出　　处：《中国小儿急救医学》2018年第3期182-185,共4页Chinese Pediatric Emergency Medicine

摘　　要：儿茶酚胺类药物是休克救治中的重要一环，其最佳目的是维持患者血压的同时增加组织器官的有效灌注，改善微循环，防止多器官功能障碍的发生，但在目前的临床实践中，儿茶酚胺类药物常常是把“双刃剑”。因此，关注每个药物获益的同时兼顾药物带来的不良反应可能是寻找最佳方案的关键。Catecholamines is an important part of the treatment of shock.Its best goal is not only to maintain the patient＇s blood pressure,but also to increase the effective perfusion of tissues and organs,improve microcirculation and prevent multiple organ dysfunction.But in the current clinical practice,catecholamines are often" double-edged sword".Therefore,focusing on the benefits of each catecholamine while taking into account the adverse reactions of the drug may be the key to finding the best solution.

关 键 词：儿茶酚胺 休克 不良反应 

分 类 号：R459.7[医药卫生—急诊医学]